Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19

Macrophage biomimetic nanocarriers for anti-inflammation and targeted antiviral treatment in COVID-19

Abstract Background The worldwide pandemic of COVID-19 remains a serious public health menace as the lack of efficacious treatments. Cytokine storm syndrome (CSS) characterized with elevated inflammation and multi-organs failure is closely correlated with the bad outcome of COVID-19. Hence, inhibit...

Full description

Bibliographic Details
Main Authors: Qingqin Tan, Lingjie He, Xiaojun Meng, Wei Wang, Hudan Pan, Weiguo Yin, Tianchuan Zhu, Xi Huang, Hong Shan
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Journal of Nanobiotechnology
Subjects:
COVID-19
Cytokine storm syndrome
Anti-inflammation
Antiviral treatment
Biomimetic nanocarriers
Online Access:https://doi.org/10.1186/s12951-021-00926-0

Internet

https://doi.org/10.1186/s12951-021-00926-0

Similar Items